Sodium hydride → 2-(4-((2'-Chloro-4',4'-difluoro-4,5'-dihydrospiro[piperidine-4,7'-thieno[2,3-c]pyran]-1-yl)methyl)-3-methyl-1H-pyrazol-1-yl)-3-(3-methyl-1,2,4-oxadiazol-5-yl)-pyridine

HRID 1517619노트

반응식

HRID 1517619 반응식
[C:1](=[N:4][OH:5])([NH2:3])[CH3:2].[H-].[Na+].CO[C:10](=O)[C:11]1[CH:16]=[CH:15][CH:14]=[N:13][C:12]=1[N:17]1[CH:21]=[C:20]([CH2:22][N:23]2[CH2:39][CH2:38][C:26]3([C:31]4[S:32][C:33]([Cl:35])=[CH:34][C:30]=4[C:29]([F:37])([F:36])[CH2:28][O:27]3)[CH2:25][CH2:24]2)[C:19]([CH3:40])=[N:18]1>O1CCCC1>[Cl:35][C:33]1[S:32][C:31]2[C:26]3([CH2:25][CH2:24][N:23]([CH2:22][C:20]4[C:19]([CH3:40])=[N:18][N:17]([C:12]5[C:11]([C:10]6[O:5][N:4]=[C:1]([CH3:2])[N:3]=6)=[CH:16][CH:15]=[CH:14][N:13]=5)[CH:21]=4)[CH2:39][CH2:38]3)[O:27][CH2:28][C:29]([F:36])([F:37])[C:30]=2[CH:34]=1

참가 물질

5

반응물 3

HCID 24758Sodium hydrideHCID 30926N-HydroxyacetamidineHCID 671682472-(4-((2'-chloro-4',4'-difluoro-4',5'-dihydrospiro[piperidine-4,7'-thieno[2,3-c]pyran]-1-yl)methyl)-3-methyl-1H-pyrazol-1-yl)-nicotinic acid methyl ester

생성물 1

HCID 582686012-(4-((2'-Chloro-4',4'-difluoro-4,5'-dihydrospiro[piperidine-4,7'-thieno[2,3-c]pyran]-1-yl)methyl)-3-methyl-1H-pyrazol-1-yl)-3-(3-methyl-1,2,4-oxadiazol-5-yl)-pyridine수율 22.2%

시약·촉매·용매 1

HCID 8028Tetrahydrofuran용매

반응 조건

온도
50 °C

실험 절차

To a solution of acetamide oxime (154 mg, 2.1 mmol) in 7 mL tetrahydrofuran, are added under argon 139 mg of grinded 4A molecular sieves and sodium hydride (2.1 mmol; 84 mg as 60% in mineral oil). The mixture is allowed to stir for 30 min at 50° C. After cooling to room temperature, 2-(4-((2′-chloro-4′,4′-difluoro-4′,5′-dihydrospiro[piperidine-4,7′-thieno[2,3-c]pyran]-1-yl)methyl)-3-methyl-1H-pyrazol-1-yl)-nicotinic acid methyl ester (309 mg, 0.6 mmol) is added and then the mixture is heated at 50° C. for 40 min. Quenched after cooling with water and extracted with dichloromethane. After drying the organic phase with magnesium sulfate and evaporation of the solvent, the residue is diluted in methanol and purified using a 5 g SCX cartridge. The resulting residue is further purified by semipreparative reverse phase HPLC_MS using a XBridge column (Sum, 19×100 mm) and a gradient between 60 and 80% of B in A in 5 min at flow 25 mL/min (basic conditions A: ammonium bicarbonate 20 mM pH9 and B: acetonitrile) to give 71 mg of the title compound. MS (m/z): 533 (M+1).

후처리

  1. temperatureAfter cooling to room temperature
  2. temperaturethe mixture is heated at 50° C. for 40 min
  3. customQuenched
  4. temperatureafter cooling with water
  5. extractionextracted with dichloromethane
  6. customAfter drying the organic phase
  7. customwith magnesium sulfate and evaporation of the solvent
  8. additionthe residue is diluted in methanol
  9. custompurified
  10. customThe resulting residue is further purified by semipreparative reverse phase HPLC_MS
  11. waita gradient between 60 and 80% of B in A in 5 min at flow 25 mL/min (basic conditions A: ammonium bicarbonate 20 mM pH9 and B

출처 및 근거

ORD 기록
ord-adceefae5e2d4ff6894ee205a1ff03b9
출처 데이터셋
uspto-grants-2012_07
특허 번호
US08232289B2

반응 노트

불러오는 중…